Cargando…

One-pot synthesis of biodegradable polydopamine-doped mesoporous silica nanocomposites (PMSNs) as pH-sensitive targeting drug nanocarriers for synergistic chemo-photothermal therapy

Nanomaterials have been widely used as drug carriers in the biomedical field. However, most of them have limited application because of their poor biocompatibility, targeting, and degradability. Therefore, exploring and developing novel drug nanocarriers to overcome these problems has widely attract...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Huicong, Wang, Xuandong, Wang, Peiyuan, Liu, Rong, Hou, Xuemei, Cao, Wei, Zhong, Rong, Liu, Xiaolong, Zhang, Yun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089436/
https://www.ncbi.nlm.nih.gov/pubmed/35557807
http://dx.doi.org/10.1039/c8ra07467d
_version_ 1784704518111363072
author Zhang, Huicong
Wang, Xuandong
Wang, Peiyuan
Liu, Rong
Hou, Xuemei
Cao, Wei
Zhong, Rong
Liu, Xiaolong
Zhang, Yun
author_facet Zhang, Huicong
Wang, Xuandong
Wang, Peiyuan
Liu, Rong
Hou, Xuemei
Cao, Wei
Zhong, Rong
Liu, Xiaolong
Zhang, Yun
author_sort Zhang, Huicong
collection PubMed
description Nanomaterials have been widely used as drug carriers in the biomedical field. However, most of them have limited application because of their poor biocompatibility, targeting, and degradability. Therefore, exploring and developing novel drug nanocarriers to overcome these problems has widely attracted attention. In this study, polydopamine-doped mesoporous silica nanocomposites (PMSNs) were controllably synthesized by a one-pot oil-water biphase stratification approach. PMSNs showed good biodegradability in degradation experiments and also proved to have superior biocompatibility toward hepatocellular carcinoma cells (HepG2) compared with mesoporous silica nanoparticles (MSNs). And PMSNs loaded doxorubicin (DOX) (PMSNs@DOX) exhibited a pH-responsive release effect. Meanwhile, compared with PMSNs@DOX, folic acid-modified PMSNs@DOX (PMSNs@DOX@FA) displayed a targeted uptake and higher inhibition of HepG2 cells. Additionally, PMSNs@DOX@FA had excellent ability to kill tumor cells under synergistic chemo-photothermal therapy. Moreover, this synthetic strategy is promising for the fabrication of unique nanocomposites with various functional cores with PMSNs shells for diverse applications.
format Online
Article
Text
id pubmed-9089436
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-90894362022-05-11 One-pot synthesis of biodegradable polydopamine-doped mesoporous silica nanocomposites (PMSNs) as pH-sensitive targeting drug nanocarriers for synergistic chemo-photothermal therapy Zhang, Huicong Wang, Xuandong Wang, Peiyuan Liu, Rong Hou, Xuemei Cao, Wei Zhong, Rong Liu, Xiaolong Zhang, Yun RSC Adv Chemistry Nanomaterials have been widely used as drug carriers in the biomedical field. However, most of them have limited application because of their poor biocompatibility, targeting, and degradability. Therefore, exploring and developing novel drug nanocarriers to overcome these problems has widely attracted attention. In this study, polydopamine-doped mesoporous silica nanocomposites (PMSNs) were controllably synthesized by a one-pot oil-water biphase stratification approach. PMSNs showed good biodegradability in degradation experiments and also proved to have superior biocompatibility toward hepatocellular carcinoma cells (HepG2) compared with mesoporous silica nanoparticles (MSNs). And PMSNs loaded doxorubicin (DOX) (PMSNs@DOX) exhibited a pH-responsive release effect. Meanwhile, compared with PMSNs@DOX, folic acid-modified PMSNs@DOX (PMSNs@DOX@FA) displayed a targeted uptake and higher inhibition of HepG2 cells. Additionally, PMSNs@DOX@FA had excellent ability to kill tumor cells under synergistic chemo-photothermal therapy. Moreover, this synthetic strategy is promising for the fabrication of unique nanocomposites with various functional cores with PMSNs shells for diverse applications. The Royal Society of Chemistry 2018-11-07 /pmc/articles/PMC9089436/ /pubmed/35557807 http://dx.doi.org/10.1039/c8ra07467d Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Zhang, Huicong
Wang, Xuandong
Wang, Peiyuan
Liu, Rong
Hou, Xuemei
Cao, Wei
Zhong, Rong
Liu, Xiaolong
Zhang, Yun
One-pot synthesis of biodegradable polydopamine-doped mesoporous silica nanocomposites (PMSNs) as pH-sensitive targeting drug nanocarriers for synergistic chemo-photothermal therapy
title One-pot synthesis of biodegradable polydopamine-doped mesoporous silica nanocomposites (PMSNs) as pH-sensitive targeting drug nanocarriers for synergistic chemo-photothermal therapy
title_full One-pot synthesis of biodegradable polydopamine-doped mesoporous silica nanocomposites (PMSNs) as pH-sensitive targeting drug nanocarriers for synergistic chemo-photothermal therapy
title_fullStr One-pot synthesis of biodegradable polydopamine-doped mesoporous silica nanocomposites (PMSNs) as pH-sensitive targeting drug nanocarriers for synergistic chemo-photothermal therapy
title_full_unstemmed One-pot synthesis of biodegradable polydopamine-doped mesoporous silica nanocomposites (PMSNs) as pH-sensitive targeting drug nanocarriers for synergistic chemo-photothermal therapy
title_short One-pot synthesis of biodegradable polydopamine-doped mesoporous silica nanocomposites (PMSNs) as pH-sensitive targeting drug nanocarriers for synergistic chemo-photothermal therapy
title_sort one-pot synthesis of biodegradable polydopamine-doped mesoporous silica nanocomposites (pmsns) as ph-sensitive targeting drug nanocarriers for synergistic chemo-photothermal therapy
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9089436/
https://www.ncbi.nlm.nih.gov/pubmed/35557807
http://dx.doi.org/10.1039/c8ra07467d
work_keys_str_mv AT zhanghuicong onepotsynthesisofbiodegradablepolydopaminedopedmesoporoussilicananocompositespmsnsasphsensitivetargetingdrugnanocarriersforsynergisticchemophotothermaltherapy
AT wangxuandong onepotsynthesisofbiodegradablepolydopaminedopedmesoporoussilicananocompositespmsnsasphsensitivetargetingdrugnanocarriersforsynergisticchemophotothermaltherapy
AT wangpeiyuan onepotsynthesisofbiodegradablepolydopaminedopedmesoporoussilicananocompositespmsnsasphsensitivetargetingdrugnanocarriersforsynergisticchemophotothermaltherapy
AT liurong onepotsynthesisofbiodegradablepolydopaminedopedmesoporoussilicananocompositespmsnsasphsensitivetargetingdrugnanocarriersforsynergisticchemophotothermaltherapy
AT houxuemei onepotsynthesisofbiodegradablepolydopaminedopedmesoporoussilicananocompositespmsnsasphsensitivetargetingdrugnanocarriersforsynergisticchemophotothermaltherapy
AT caowei onepotsynthesisofbiodegradablepolydopaminedopedmesoporoussilicananocompositespmsnsasphsensitivetargetingdrugnanocarriersforsynergisticchemophotothermaltherapy
AT zhongrong onepotsynthesisofbiodegradablepolydopaminedopedmesoporoussilicananocompositespmsnsasphsensitivetargetingdrugnanocarriersforsynergisticchemophotothermaltherapy
AT liuxiaolong onepotsynthesisofbiodegradablepolydopaminedopedmesoporoussilicananocompositespmsnsasphsensitivetargetingdrugnanocarriersforsynergisticchemophotothermaltherapy
AT zhangyun onepotsynthesisofbiodegradablepolydopaminedopedmesoporoussilicananocompositespmsnsasphsensitivetargetingdrugnanocarriersforsynergisticchemophotothermaltherapy